Maxpro 40 mg Capsule contains esomeprazole, a proton pump inhibitor that reduces stomach acid by blocking the acid pump in the stomach lining. It is used for acid-related conditions such as GERD and ulcers.
There are 161 brands of Esomeprazole listed in Bangladesh. 51 of them have a lower unit price than Maxpro. The lowest listed price is Emo 20 mg Tablet at ৳ 1 per unit.
What is Maxpro 40 mg Capsule?
Maxpro 40 mg Capsule is a medicine that reduces the amount of acid produced in the stomach. It contains esomeprazole, which belongs to a group called proton pump inhibitors. These work by blocking the tiny pumps in the stomach lining that release acid. This helps relieve symptoms like heartburn and allows irritated areas in the food pipe to heal. Doctors prescribe it for conditions such as gastro-oesophageal reflux disease (GERD), erosive esophagitis, and, in combination with antibiotics, to clear Helicobacter pylori infection in people with duodenal ulcers. It is available as a capsule in 40 mg strength.
Uses of Maxpro
Maxpro 40 mg Capsule is used to treat conditions where stomach acid causes problems. These include relieving chronic heartburn and other symptoms of GERD, healing erosive esophagitis (damage to the food pipe from acid), and maintaining healing once it has occurred. It is also used together with two antibiotics to eradicate Helicobacter pylori infection in patients with duodenal ulcer disease. Your doctor will decide if this medicine is suitable for your specific condition.
How to use Maxpro
Take Maxpro 40 mg Capsule exactly as your doctor prescribes. Swallow the capsule whole with water; do not crush or chew it. It is usually taken at least one hour before meals. If you have trouble swallowing capsules, your doctor or pharmacist can advise on whether the contents may be mixed with a small amount of soft, non-hot applesauce and swallowed immediately without chewing. The dose and length of treatment depend on your condition and will be decided by your doctor. Do not stop or change the dose without medical advice.
Side effects of Maxpro
Like all medicines, Maxpro 40 mg Capsule can cause side effects, though not everyone experiences them. The most common ones reported include headache, diarrhoea, nausea, flatulence, abdominal pain, constipation, and dry mouth. These are usually mild, but if they bother you or do not go away, talk to your doctor or pharmacist. Serious side effects are rare. Always seek medical advice if you notice any unexpected or severe symptoms while taking this medicine.
Safety and precautions
Before taking Maxpro 40 mg Capsule, tell your doctor if you are allergic to esomeprazole or any of its ingredients, or if you have liver problems or other health conditions. Do not use it if you are hypersensitive to any component. There are no adequate studies in pregnant women; animal studies showed no harm to the foetus, but use in pregnancy should be discussed with your doctor. It is not known if esomeprazole passes into breast milk, so breastfeeding may need to be stopped if this medicine is essential. Always consult your doctor first if you are pregnant, planning pregnancy, or breastfeeding.
Frequently asked questions
What medicines can interact with Maxpro 40 mg Capsule?
Esomeprazole is broken down in the liver by certain enzymes and may affect how some medicines work. It can potentially interact with drugs like diazepam. However, studies show no clinically significant interactions with phenytoin, warfarin, quinidine, clarithromycin, or amoxicillin. Always tell your doctor or pharmacist about all medicines you take, including over-the-counter ones, to avoid problems.
What is Maxpro 40 mg Capsule used for and what kind of medicine is it?
Maxpro 40 mg Capsule is a proton pump inhibitor. It reduces stomach acid and is used to treat GERD symptoms, heal erosive esophagitis, maintain healing, and, with antibiotics, to eradicate Helicobacter pylori in duodenal ulcer patients. It helps relieve heartburn and allows irritation to heal. Your doctor will determine if it is right for you.
What does the dosage form and strength mean?
Maxpro is supplied as a capsule, a solid dosage form that you swallow whole. The strength is 40 mg, meaning each capsule contains 40 milligrams of esomeprazole. The strength is chosen by your doctor based on your condition. Do not adjust your dose without medical advice.
How should I store Maxpro 40 mg Capsule?
Store at a temperature not exceeding 30°C in a dry place. Protect from light and moisture. Keep out of reach of children. Do not use after the expiry date. Always check the packaging for storage instructions and ask your pharmacist if you are unsure.
To relieve from chronic heartburn symptoms and other symptoms associated with GERD
For the healing of erosive esophagitis
For maintenance of healing of erosive esophagitis
In combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori infection in patients with duodenal ulcer disease.
... Read more
Esomeprazole is indicated:
To relieve from chronic heartburn symptoms and other symptoms associated with GERD
For the healing of erosive esophagitis
For maintenance of healing of erosive esophagitis
In combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori infection in patients with duodenal ulcer disease.
Zollinger-Ellison Syndrome
Acid related Dyspepsia
Duodenal & Gastric ulcer
Pharmacology
Esomeprazole is a proton pump inhibitor that suppresses gastric acid secretion by specific inhibition of the H+/K+-ATPase in the gastric parietal cell. Esomeprazole (S-isomer of omeprazole) is the first single optical isomer of proton pump inhibitor, provides better acid control than racemic proton pump inhibitors.
Absorption: Esomeprazole capsules contain an enteric-coated pellet formulation of esomeprazole magnesium. After oral administration peak plasma levels (Cmax) occur at approximately 1.5 hours (Tmax). The Cmax increases proportionally when the dose is increased, and there is a three-fold increase in the area under the plasma concentration-time curve (AUC) from 20 to 40 mg. At repeated once daily dosing, the systemic bioavailability is approximately 90% compared to 64% after a single dose. The AUC after administration of a single dose of esomeprazole is decreased by 33-53% after food intake compared to fasting conditions. Esomeprazole should be taken at least one hour before meals.
Distribution: Esomeprazole is 97% bound to plasma proteins. Plasma protein binding is constant over the concentration range of 2 20 mmol/L. The apparent volume of distribution at steady state in healthy volunteers is approximately 16 L.
Metabolism: Esomeprazole is extensively metabolized in the liver by the cytochrome P450 (CYP) enzyme system. The metabolites of esomeprazole lack anti-secretory activity. The major part of esomeprazole’s metabolism is dependent upon the CYP2C19 isoenzyme, which forms the hydroxy and desmethyl metabolites. The remaining amount is dependent on CYP3A4 which forms the sulphone metabolite.
Excretion: The plasma elimination half-life of esomeprazole is approximately 1–1.5 hours. Less than 1% of parent drug is excreted in the urine. Approximately 80% of an oral dose of esomeprazole is excreted as inactive metabolites in the urine, and the remainder is found as inactive metabolites in the faeces.
Combination Therapy with Antimicrobials: Esomeprazole magnesium 40 mg once daily is given in combination with clarithromycin 500 mg twice daily and amoxicillin 1000 mg twice daily for 7 days. The mean steady state AUC and Cmax of Esomeprazole increased by 70% and 18%, respectively, during triple combination therapy compared to treatment with Esomeprazole alone. The pharmacokinetic parameters for clarithromycin and amoxicillin are similar during triple combination therapy and administration of each drug alone. However, the mean AUC and Cmax for 14-hydroxyclarithromycin are increased by 19% and 22%, respectively, during triple combination therapy compared to treatment with clarithromycin alone. This increase in exposure to 14-hydroxyclarithromycin is not considered to be clinically significant.
Dosage & Administration
Healing of Erosive Esophagitis: 20 mg or 40 mg Once Daily for 4-8 Weeks. The majority of patients are healed within 4 to 8 weeks. For patients who don't heal after 4-8 weeks, an additional 4-8 weeks of treatment may be considered. Maintenance of Healing of Erosive
Esophagitis: 20 mg Once Daily (Clinical studies did not extend 6 months).
Symptomatic GERD: 20 mg Once Daily for 4 Weeks. If symptoms do not resolve completely after 4 weeks, an additional 4 weeks of treatment may be considered.
Helicobacter Pylori eradication: Triple Therapy to reduce the risk of Duodenal Ulcer recurrence-Esomeprazole 40 mg Once Daily for 10 days, Amoxicillin 1000 mg Twice Daily for 10 days, Clarithromycin 500 mg Twice Daily for 10 days.
Zollinger-Ellison Syndrome: The dose is 20-80 mg once daily. The dosage should be adjusted individually and treatment continued as long as clinically indicated.
Acid-related Dyspepsia: 20-40 mg once daily for 2-4 weeks according to the response.
Duodenal ulcer: 20 mg once daily for 2-4 weeks. Gastric ulcer: 20-40 mg once daily for 4-8 weeks.
Injection: The recommended adult dose is 40 mg Esomeprazole given once daily by intravenous injection (not less than 3 minutes) or intravenous infusion (10 to 30 minutes). Esomeprazole IV injection should not be administered concomitantly with any other medications through the same intravenous site. Treatment with Esomeprazole IV injection should be discontinued as soon as the patient is able to resume treatment with Esomeprazole delayed-release capsules. Safety and effectiveness in paediatric patients have not been established.
Interaction
Esomeprazole is extensively metabolized in the liver by CYP2C19 and CYP3A4. In vitro and in vivo studies have shown that Esomeprazole is not likely to inhibit CYPs 1A2, 2A6, 2C9, 2D6, 2E1 and 3A4. No clinically relevant interactions with drugs metabolized by these CYP enzymes would be expected. Drug interaction studies have shown that Esomeprazole does not have any clinically significant interactions with phenytoin, warfarin, quinidine, clarithromycin or amoxicillin.
Esomeprazole may potentially interfere with CYP2C19, the major Esomeprazole metabolizing enzyme. Co-administration of Esomeprazole 30 mg and diazepam, a CYP2C19 substrate has resulted in a 45% decrease in clearance of diazepam. Increased plasma levels of diazepam have been observed 12 hours after dosing and onwards. Esomeprazole inhibits gastric acid secretion. Therefore, Esomeprazole may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability (e.g., ketoconazole, iron salts and digoxin).
Co-administration of oral contraceptives, diazepam, phenytoin, or quinidine do not seem to change the pharmacokinetic profile of Esomeprazole.
Combination Therapy with Clarithromycin: Co-administration of esomeprazole, clarithromycin, and amoxicillin has resulted in increases in the plasma levels of esomeprazole and 14-hydroxyclarithromycin.
Contraindications
Esomeprazole is contraindicated in-patient with known hypersensitivity to any of the formulation.
Side Effects
The most frequently occurring adverse events reported with Esomeprazole include headache, diarrhoea, nausea, flatulence, abdominal pain, constipation and dry mouth. There are no difference in types of related adverse events seen during maintenance treatment upto 12 months compared to short term treatment.
Pregnancy & Lactation
There are no adequate and well-controlled studies in pregnant women. Animal studies have revealed no teratogenic effects. The excretion of esomeprazole in milk has not been studied. Breast-feeding should be therefore be discontinued if the use of esomeprazole is considered essential.
Precautions & Warnings
General: Symptomatic response to therapy with esomeprazole does not preclude the presence of gastric malignancy.
Information for patients: Esomeprazole capsules should be taken at least one hour before meals. For patients who have difficulty swallowing capsules, one tablespoon of applesauce can be added to an empty bowl and the Esomeprazole capsules can be opened, and the pellets inside the capsule carefully emptied onto the applesauce. The pellets should be mixed with the applesauce and then swallowed immediately. The applesauce used should not be hot and should be soft enough to be swallowed without chewing. The pellets should not be chewed or crushed. The pellet/applesauce mixture should not be stored for future use. Antacids may be used while taking esomeprazole.
Overdose Effects
A single oral dose of Esomeprazole at 510 mg/kg (about 103 times the human dose on a body surface area basis), has been lethal to rats. The major signs of acute toxicity are reduced motor activity, changes in respiratory frequency, tremor, ataxia, and intermittent clonic convulsions. There have been no reports of overdose with Esomeprazole. No specific antidote for Esomeprazole is known. Since Esomeprazole is extensively protein bound, it is not expected to be removed by dialysis. In the event of overdosage, treatment should be symptomatic and supportive. As with the management of any overdose, the possibility of multiple drug ingestion should be considered.
Storage Conditions
Store at a temperature not exceeding 30°C in a dry place. Protect from light and moisture. Keep out of reach of children.
Alternative brands of Esomeprazole
Other brands with the same generic name, cheapest first.